IRIS
AVOLIO, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.955
NA - Nord America 2.608
AS - Asia 1.274
SA - Sud America 134
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 11
OC - Oceania 7
Totale 7.004
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.590
IE - Irlanda 881
CN - Cina 548
UA - Ucraina 482
SE - Svezia 387
IT - Italia 303
RU - Federazione Russa 284
SG - Singapore 282
HK - Hong Kong 267
DE - Germania 190
FR - Francia 130
BR - Brasile 126
FI - Finlandia 122
IN - India 72
GB - Regno Unito 65
TR - Turchia 62
BE - Belgio 39
AT - Austria 21
EU - Europa 15
NL - Olanda 14
CA - Canada 9
IR - Iran 9
AU - Australia 7
CZ - Repubblica Ceca 7
SC - Seychelles 6
MX - Messico 5
PK - Pakistan 5
PT - Portogallo 5
ES - Italia 4
ID - Indonesia 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
LT - Lituania 3
PL - Polonia 3
AR - Argentina 2
CH - Svizzera 2
EC - Ecuador 2
EE - Estonia 2
HR - Croazia 2
JP - Giappone 2
KR - Corea 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MN - Mongolia 2
RO - Romania 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BZ - Belize 1
CI - Costa d'Avorio 1
CL - Cile 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
VN - Vietnam 1
Totale 7.004
Salva come PNG Salva come JPEG
Città #
Dublin 880
Chandler 403
Jacksonville 326
Nyköping 286
Dearborn 269
Hong Kong 262
Nanjing 145
Santa Clara 118
Princeton 90
Wilmington 88
Singapore 83
Helsinki 69
Ashburn 68
Moscow 66
Nanchang 65
Beijing 61
Woodbridge 60
Ann Arbor 58
San Mateo 51
The Dalles 48
New York 45
Brussels 39
Boardman 37
Des Moines 33
Jiaxing 33
Shenyang 30
Foggia 29
Tianjin 25
Munich 24
Cedar Knolls 21
Changsha 21
Hebei 21
Los Angeles 21
Kunming 19
Nuremberg 18
Rome 18
Guangzhou 15
Bari 14
Hangzhou 14
Zhengzhou 14
San Severo 12
Falkenstein 11
Hilden 11
Ningbo 11
Norwalk 11
Redwood City 11
Seattle 11
Taizhou 11
Jinan 10
Milan 10
Frankfurt am Main 9
Kocaeli 9
Pimonte 9
Assago 8
Auburn Hills 8
Buffalo 8
Lanzhou 8
Naples 8
Falls Church 7
São Paulo 7
Council Bluffs 6
Fortaleza 6
Hanover 6
Wuhan 6
Belo Horizonte 5
Bologna 5
Brasília 5
Düsseldorf 5
London 5
Ottawa 5
Pune 5
Santeramo In Colle 5
Trento 5
Vienna 5
West Jordan 5
Brindisi 4
Béligneux 4
Cascina 4
Espoo 4
Jakarta 4
Meda 4
Roanoke 4
Shanghai 4
Tehran 4
Terlizzi 4
Tsuen Wan 4
Turku 4
Campinas 3
Canberra 3
Chicago 3
Curitiba 3
Fiorano Modenese 3
Lauterbourg 3
Lucera 3
Manfredonia 3
Melbourne 3
Padova 3
Prague 3
Rio de Janeiro 3
Saint Petersburg 3
Totale 4.343
Salva come PNG Salva come JPEG
Nome #
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 150
Serial immunoprecipitation assays for interferon-(IFN)-beta antibodies in multiple sclerosis patients. 122
Serum Soluble Intercellular Adhesion Molecule-1 in MS: relation to clinical and Gd-MRI activity, and to rIFNβ-1b treatment. 117
Defining the electroclinical phenotype and outcome of PCDH19‐related epilepsy: A multicenter study 105
Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population. 105
Changes of serum ICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS. 104
Usefulness of a standardized method for collecting anamnestic data in multiple sclerosis (MS). 104
Design of a European multicenter study dedicated to the evaluation of the EDMUS system: EVALUED. 103
Espressione di LFA-1 su linfociti memoria CD4+CD45RO+ si sangue periferico nella Sclerosi Multipla remittente: effetti indotti dall’ IFN b-1a. 100
Comparison of Clinical and demographic features between affected pairs of Italian Multiple Sclerosis Multiplex families; relation to Tumor Necrosis Factor genomic polymorphisms. 99
CSF and serum soluble adhesion molecules in Multiple Sclerosis 99
Analisi fenotipica di linfociti T di pazienti con Sclerosi multipla (SM) nel sangue periferico ed in coltura con e senza aggiunta di mitogeni 99
Adhesion molecules and matrix metalloproteinases in MS: effects induced by Interferon beta. 98
L’ esame del liquor (CSF) nella diagnosi di Sclerosi Multipla (SM) 98
Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells 98
Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination. 97
Between-laboratory variability in oligoclonal IgG band numbering. 97
Intrathecal IgG synthesis in Multiple Sclerosis 97
European Validation of a Standardized Clinical Description of Multiple Sclerosis. 96
Analisi liquorale per la diagnosi ed il follow-up di malattie infiammatorie del SNC. 95
Disease duration, relapse rate and clinical course in Multiple Sclerosis. Relation to IgG production within the blood-brain barrier. 94
Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a. 92
T regulatory cells are markers of disease activity in multiple sclerosis patients. 92
Epstein–Barr virus (EBV) and multiple sclerosis association: EBV has a primary or secondary role? 90
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients. 89
Counting of peripheral extracellular vesicles in Multiple Sclerosis patients by an improved nanoplasmonic assay and dynamic light scattering 89
Wernicke's encephalopathy following reduced food intake due to depressive disorders. 88
The epilepsy phenotype in adult patients with intellectual disability and pathogenic copy number variants 88
Il ruolo dell’ esame del liquor 87
Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. 86
Soluble Intercellular adhesion molecule-1 (sICAM-1) in serum and cerebrospinal fluid of demyelinating diseases of the central and the peripheral nervous system. 86
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in Multiple Sclerosis: relationships with different MRI measures of disease activity during IFN-beta-1a treatment. 85
Soluble Intercellular Adhesion Molecule-1 in serum and cerebrospinal fluid (CSF) of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA Magnetic Resonance Imaging enhancement and CSF findings. 85
Effects of rIFNbeta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells. 85
Age-Related Disability in Multiple Sclerosis. 83
LFA-1 expressing CD4+CD45RO+ peripheral blood T-lymphocytes in RR MS: effects induced by rIFNbeta-1a. 82
Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment. 82
Sopluble Intercellular Adhesion Molecule-1 (sICAM-1) nel siero e liquor di pazienti con sclerosi multipla remittente clinicamente attiva: correlazioni con lesioni RMI che assumono gadolinio e con parametri liquorali 82
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. 81
Serum MMP-2 and MMP-9 are elevated in different Multiple Sclerosis subtypes. 81
New Insights Into Immune Cell-Derived Extracellular Vesicles in Multiple Sclerosis. 81
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis 80
Glatiramer Acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from Multiple Sclerosis patients. 79
P2X7 purinergic receptor on monocytes of patients with Multiple Sclerosis: effects of Glatiramer Acetate immune modulation 79
Quantitation of intrathecal measles virus IgG antibody synthesis rate: Subacute sclerosing panencephalitis and multiple sclerosis. 78
Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlations 78
Effetti antinfiammatori dell’ Interferone beta-1b ricombinante nella Sclerosi Multipla: studio longitudinale dei livelli sierici della forma solubile di Intercellular Adhesion Molecule-1 (sICAM-1) e dei subsets linfocitari 76
First-aid management of tonic-clonic seizures among healthcare personnel: A survey by the Apulian section of the Italian League Against Epilepsy 76
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 76
Interferon beta in relapsing / remitting multiple sclerosis: an independent postmarketing study in southern Italy. 75
Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients. 73
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 73
MicroRNAs 181a and 125a are highly expressed in naïve RRMS: a pilot case-control study 72
Late-onset Leber hereditary optic neuropathy mimiking Susac’s syndrome 72
Glatiramer Acetate in Multiple Sclerosis: a review 71
Fisiopatologia della risposta immunitaria nel compartimento liquorale. XXXVII Congress of the Italian Neurological Society, Bari 14-18 October 2006. 71
Usefulness of a standardised collection of disease events for clinical studies in Multiple Sclerosis. 70
Effect of fingolimod action on the release of monocyte-derived microvesicles in multiple sclerosis patients. 69
Faciobrachial dystonic seizures expressed as epileptic spasms, followed by focal seizures in anti-LGI1 encephalitis: a video-polygraphic study. 69
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 69
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 69
Prognostic indicators in pediatric clinically isolated syndrome. 68
Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease 68
How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study. 66
IMMUNOSENESCENCE AND MULTIPLE SCLEROSIS: PROGNOSTIC AND THERAPEUTIC IMPLICATIONS 65
Fluctuations of MS births and UV-light exposure. 65
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 64
Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion. 63
Molecular Characterization of Peripheral Extracellular Vesicles in Clinically Isolated Syndrome: Preliminary Suggestions from a Pilot Study 62
The Italian multiple sclerosis register 60
Brivaracetam in Absence Status Epilepticus 60
Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis. 60
IgG and IgM antibodies to the refolded MOG(1-125) extracellular domain in humans. 59
Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production. 59
Treatment with metformin in twelve patients with Lafora disease 56
Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line 55
Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications 51
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 51
Perceptive and Subjective Evaluation of Speech Disorders in Parkinson's Disease 51
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register. 49
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders 47
Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression (Q1 WoS) 45
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 45
First-line therapies in Late Onset Multiple Sclerosis: an Italian registry study 43
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 43
The effect of quarantine due to Covid-19 pandemic on seizure frequency in 102 adult people with epilepsy from Apulia and Basilicata regions, Southern Italy 39
Real world comparison of teriflunomide and dimethyl fumarate in naïve relapsing multiple sclerosis patients: Evidence from the Italian MS register 39
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study 38
Guillain-Barré syndrome as only manifestation of COVID-19 infection 36
An Association of Framingham Risk Score with Patient Determined Disease Steps in a Cohort of Relapsing-Remitting Multiple Sclerosis Patients: An Italian Real-World Monocentric Experience 35
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease 35
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 35
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register 35
THE PRESENTING SYMPTOMS OF LAFORA DISEASE: AN ELECTROCLINICAL AND GENETIC STUDY IN FIVE APULIAN (SOUTHERN ITALY) FAMILIES 34
Real-life impact of early interferonβ therapy in relapsing multiple sclerosis 34
Predictive factors of Status Epilepticus and its recurrence in patients with adult-onset seizures: A multicenter, long follow-up cohort study 33
Myeloid-derived Suppressor Cells and Multiple Sclerosis 29
Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies 29
Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful 29
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register 28
Totale 7.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.889
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202094 0 0 0 0 0 0 0 0 0 0 74 20
2020/2021652 78 3 75 29 91 28 93 46 92 110 3 4
2021/2022540 70 12 16 15 41 10 19 30 66 56 40 165
2022/20232.491 198 129 105 157 119 191 18 144 1.049 117 186 78
2023/2024389 65 55 23 24 43 69 32 17 4 8 18 31
2024/20251.579 64 37 55 54 57 247 194 174 483 156 58 0
Totale 7.669